A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.

Clinical trial NCT00386555 · WITHDRAWN

Trial details

NCT number: NCT00386555
Sponsor: Arog Pharmaceuticals, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2007-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.